Related Experiment Video
Updated: Aug 9, 2026

Enumeration of Major Peripheral Blood Leukocyte Populations for Multicenter Clinical Trials Using a Whole Blood Phenotyping Assay
Published on: September 16, 2012
The NHLBI Clinical Trials Network in transfusion medicine and hemostasis: an overview
1Blood Transfusion Service, Boston, Massachusetts General Hospital and Harvard Medical School, Boston, 02114, USA. sdzik@partners.org
Transfusion Medicine is a broad discipline that affects the health care of patients from many medical disciplines. Despite the large impact of transfusion therapies on the management of patients with a variety of diseases, there are few clinical trials that evaluate the indications or the effectiveness of transfusion therapies. To respond to this need for better clinical data, the National Heart Lung and Blood Institute of the National Institutes of Health established a clinical trials network in Transfusion Medicine and Hemostasis. Following a competitive selection process, 17 university medical centers and a data coordinating center joined together to collaboratively address clinical questions in transfusion medicine and hemostasis. The activities, organization, and scope of the network is described below. Examples of clinical trials currently in the network "pipeline" are briefly summarized as an overview to more detailed presentations given elsewhere in this symposium.
Transfusion Medicine is a broad discipline that affects the health care of patients from many medical disciplines. Despite the large impact of transfusion therapies on the management of patients with a variety of diseases, there are few clinical trials that evaluate the indications or the effectiveness of transfusion therapies. To respond to this need for better clinical data, the National Heart Lung and Blood Institute of the National Institutes of Health established a clinical trials network in Transfusion Medicine and Hemostasis. Following a competitive selection process, 17 university medical centers and a data coordinating center joined together to collaboratively address clinical questions in transfusion medicine and hemostasis. The activities, organization, and scope of the network is described below. Examples of clinical trials currently in the network "pipeline" are briefly summarized as an overview to more detailed presentations given elsewhere in this symposium.
Related Concept Videos
Blood Transfusion
Blood Transfusion Overview
A blood transfusion is a medical procedure used to replace blood lost due to injury, surgery, or to treat conditions such as anemia or cancer. During a transfusion, donor blood is...
Clinical Trials
There are four phases in a clinical trial. A phase one...
Blood Transfusion and Agglutination
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Bone Marrow Sampling and Transplants
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
Introduction to Hemostasis
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized, and...